Fig. 4From: Impact of SGLT-2 inhibitors on modifiable cardiovascular risk factors in Romanian patients with type 2 diabetes mellitusImpact of SGLT-2i on the cardiovascular system.Abbreviations: SBP: systolic blood pressure, DBP: diastolic blood pressure, NT-proBNP: N-terminal pro b-type natriuretic peptideBack to article page